Skip to content

Bioalmanac

CJC-1295 / Ipamorelin

CJC ipa · CJC-1295 with ipamorelin · CJC/Ipa blend

Preclinical

Status reviewed 25 Aug 2026

Prohibited in sport

The default growth hormone blend: a GHRH analogue with a ghrelin agonist, usually 5 mg of each. Two mechanisms that genuinely differ, unlike the triple.

Storage

Freeze-dried powder
Refrigerated at 2–8 °C, protected from light.
After mixing
Refrigerated at 2–8 °C and used within about 30 days. A blend cannot be split. A contaminated vial takes every component with it.
Long-term, frozen
Unopened powder is stable at −20 °C or colder.

Reconstitution — 10 mg vial, 200 mcg dose

On a 1 mL U-100 syringe. Check every figure against your own vial before drawing.

Water addedConcentrationVolume to drawUnitsDoses per vial
1 mL10 mg/mL0.02 mL2 units50
2 mL5 mg/mL0.04 mL4 units50
3 mL3.333 mg/mL0.06 mL6 units50
5 mL2 mg/mL0.1 mL10 units50

Dose ranges reported in sources

Descriptions of what sources report, not recommendations.

GoalRangeFrequencySource
Commonly described community protocol200–300 mcgOnce daily before bed, 5 days a weekCommunity practice

When to stop

  • Any allergic response: rash, hives, facial swelling or difficulty breathing. Seek urgent care.
  • Persistent numbness or tingling in the hands, which can indicate fluid-related nerve compression.
  • New or worsening joint swelling.

Not approved anywhere as a mixture or as either of its parts. Sold as a research chemical, in at least two vial sizes at the same ratio.

Arithmetic on values you enter. Not medical advice. Not reviewed by a clinician. · bioalmanac.com/peptides/cjc-1295-ipamorelin-blend

Use your browser’s print dialog and choose “Save as PDF”. This block is hidden when printed.